Report overview
Cognitive impairment can strike at any age, from infancy to old age. It can be brought on by a number of reasons, both reversible and irreversible. Malnutrition, prenatal drug exposure, genetic disorders, and chromosome abnormalities are also possible early causes. Because the brain keeps its neuroplasticity until late adulthood, there has been an increase in the demand for cognitive evaluation and training. Due to factors such as increased awareness about brain fitness, technological developments, and a growing geriatric population, the global Cognitive Assessment and Training Healthcare Market is predicted to rise significantly during the forecast period. Although these aspects contribute to the market's growth, the necessity for evaluations in a variety of languages might be a major impediment to the market's expansion.
This report contains market size and forecasts of Cognitive Assessment and Training Healthcare in Global, including the following market information:
Global Cognitive Assessment and Training Healthcare Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cognitive Assessment and Training Healthcare market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pen-and-paper Based Assessment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cognitive Assessment and Training Healthcare include Cambridge Cognition Ltd., Cogstate Ltd., Bracket, MedAvante Inc., Quest Diagnostic, ProPhase, LLC, CogniFit, ERT Clinical and NeuroCog Trials and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cognitive Assessment and Training Healthcare companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cognitive Assessment and Training Healthcare Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cognitive Assessment and Training Healthcare Market Segment Percentages, by Type, 2021 (%)
Pen-and-paper Based Assessment
Hosted Assessment
Biometrics Assessment
Global Cognitive Assessment and Training Healthcare Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cognitive Assessment and Training Healthcare Market Segment Percentages, by Application, 2021 (%)
Clinical Trials
Screening & Diagnostic
Brain Training
Academic Research
Others
Global Cognitive Assessment and Training Healthcare Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cognitive Assessment and Training Healthcare Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cognitive Assessment and Training Healthcare revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cognitive Assessment and Training Healthcare revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cambridge Cognition Ltd.
Cogstate Ltd.
Bracket
MedAvante Inc.
Quest Diagnostic
ProPhase, LLC
CogniFit
ERT Clinical
NeuroCog Trials
Brain Resource Company
